These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25757228)

  • 1. A public health approach to hepatitis C control in low- and middle-income countries.
    Suthar AB; Harries AD
    PLoS Med; 2015 Mar; 12(3):e1001795. PubMed ID: 25757228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A path to eradication of hepatitis C in low- and middle-income countries.
    Graham CS; Swan T
    Antiviral Res; 2015 Jul; 119():89-96. PubMed ID: 25615583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination?
    Niebel M; Singer JB; Nickbakhsh S; Gifford RJ; Thomson EC
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):700-701. PubMed ID: 28895545
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating hepatitis C in lower-income countries.
    Jayasekera CR; Barry M; Roberts LR; Nguyen MH
    N Engl J Med; 2014 May; 370(20):1869-71. PubMed ID: 24720680
    [No Abstract]   [Full Text] [Related]  

  • 5. Partnership to tackle HCV in low-income and middle-income countries.
    Das M
    Lancet Oncol; 2021 Sep; 22(9):1218. PubMed ID: 34391510
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries.
    Razavi H
    J Viral Hepat; 2021 Feb; 28(2):445. PubMed ID: 33205589
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):962-979. PubMed ID: 31941258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is hepatitis C virus eradication around the corner only 25 years after its discovery?
    Ippolito G; Capobianchi MR; Lanini S; Antonelli G
    Int J Antimicrob Agents; 2015 Feb; 45(2):111-2. PubMed ID: 25249016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV transmission in industrialized countries and resource-constrained areas.
    Thursz M; Fontanet A
    Nat Rev Gastroenterol Hepatol; 2014 Jan; 11(1):28-35. PubMed ID: 24080775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for public health success in tackling the hepatitis C virus epidemic.
    Sheerin I
    N Z Med J; 2017 Dec; 130(1467):73-77. PubMed ID: 29240743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of new hepatitis C treatments in different regions of the world.
    Wei L; Lok AS
    Gastroenterology; 2014 May; 146(5):1145-50.e1-4. PubMed ID: 24662488
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.
    Easterbrook P; Sands A; Harmanci H
    Semin Liver Dis; 2012 May; 32(2):147-57. PubMed ID: 22760654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very late HCV relapse following triple therapy for hepatitis C.
    Barreiro P; Vispo E; Maida I; Aguilera A; Fernández-Montero JV; de Mendoza C; Labarga P; Soriano V
    Antivir Ther; 2014; 19(7):723-4. PubMed ID: 24535551
    [No Abstract]   [Full Text] [Related]  

  • 14. New hepatitis C therapies.
    Pawlotsky JM
    Semin Liver Dis; 2014 Feb; 34(1):7-8. PubMed ID: 24782253
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiologic and therapeutic status study of patients with hepatitis C].
    Xu M; Shi HY; Cai WP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):135-6. PubMed ID: 21863640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C: a new horizon.
    Chang KM
    Gastroenterology; 2006 Dec; 131(6):1667-8. PubMed ID: 17188957
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis B and hepatitis C, a high stake for public health: how to reconcile health cost control and public health expenses?].
    Allerg Immunol (Paris); 1997 Sep; 29(7):215-8. PubMed ID: 9432191
    [No Abstract]   [Full Text] [Related]  

  • 18. Towards a better understanding of HCV transmission and course of infection.
    Berger A; Doerr HW
    Infection; 2004 Jun; 32(3):125. PubMed ID: 15188069
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and management of hepatitis C virus-infected children.
    Jhaveri R
    Pediatr Infect Dis J; 2011 Nov; 30(11):983-5. PubMed ID: 21997662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.